Watch the Free Workshop
Sign up for immediate access to the replay — free for IP owners, R&D teams, and business leaders in innovation-driven industries.
No spam. No commitment. Unsubscribe anytime.
Turn Your IP R&D Expenses Into Tax-Free Revenue
Discover how companies like Texas Instruments, Mattel, Caterpillar, and Google use R&D tax credits to reduce their tax bills by tens of millions — and how small and mid-sized businesses can do the same, then amplify the impact through IP licensing.
You Don't Need to Sell More to Boost Your Bottom Line
Most businesses in R&D-heavy industries are leaving significant money on the table — not because their IP isn't valuable, but because they don't know how to capture two compounding strategies at once: R&D tax credits and IP licensing.
R&D tax credits let you recoup a portion of what you've already spent on innovation. When you combine those credits with a licensing program that generates royalty income from that same IP, the revenue you earn can effectively become tax-free.
You can claim R&D tax credits for qualifying expenses from previous years and carry them forward to offset future tax liabilities — even without revenue yet.
Startups and small businesses qualify too. This workshop breaks down exactly what qualifies — including employee salaries, manufacturing activities, and contractor costs.
When you generate royalty income from your R&D IP, those credits can offset that income — effectively making your licensing revenue tax-free.
Every dollar you've invested in R&D can become the foundation for a licensing program — and a credit strategy — that pays you back for years.
Two Strategies. One Compounding Result.
R&D tax credits and IP licensing work independently — but when combined, they create a compounding financial advantage most businesses in innovation-driven industries never fully exploit.
Recover What You've Already Spent
R&D tax credits let you reclaim a percentage of qualifying expenses you've likely already incurred. This is money back from work already done.
Generate Recurring Royalty Income
IP licensing turns your R&D output into an ongoing revenue stream. Unlike a one-time sale, royalties compound over time as your licensee grows.
Offset Royalties with Credits
When your R&D credits exceed your tax liability, they can be applied against licensing income — effectively making your royalty revenue tax-free.
Build IP Value Without Added Cost
Every R&D dollar you spend builds your IP portfolio and generates potential tax credits. You're building two assets simultaneously at no additional cost.
Retroactive Claims Available
You can claim credits for qualifying R&D from prior tax years. Many businesses discover they've been missing credits for years — and can file retroactively.
Accelerate Your Licensing Program
R&D credits reduce your cost of innovation, freeing capital to invest in the licensing campaign that will commercialize your IP and generate royalty income.
What You'll Learn
Twelve focused topics covering R&D tax credit fundamentals, qualification strategies, and how to use IP licensing to maximize the financial benefit of your R&D investments.
11 Reasons R&D Tax Credits Matter
Why R&D credits are one of the most underutilized financial tools available to innovation-driven businesses of every size.
4 Inside Secrets to Qualifying R&D Expenses
The IRS criteria for qualifying R&D activities — and four insider strategies to maximize eligible claims.
8 Ways to Qualify Manufacturing Activities
Manufacturing and production activities that qualify in ways most businesses miss — eight specific pathways explained.
3 Ways to Qualify Employee Salaries
Employee compensation is one of the largest qualifying R&D expenses — but most businesses don't know how to document it correctly.
How the R&D Tax Credit Is Calculated
Step-by-step: the regular credit method, the alternative simplified credit, and how to choose between them for maximum benefit.
Which Industries Can Get R&D Tax Credits
MedTech, biotech, pharmaceuticals, high tech, manufacturing, software, agriculture, and more — which sectors qualify and to what extent.
How to Develop R&D IP for Licensing
How to shape your R&D program to produce IP that is commercially attractive to licensing partners — not all R&D output is equally licensable.
How to Use Licensing to Capitalize on IP R&D
Licensing structures and deal frameworks that work best for monetizing R&D-derived IP — designed to maximize royalty income.
Why Licensing Is a Better Go-to-Market Strategy
For most R&D-intensive businesses, licensing outperforms direct commercialization in speed, cost, risk profile, and long-term financial return.
Why Licensing Helps IP Sustain Market Leadership
How a well-structured licensing program creates competitive moats, extends IP life cycles, and dominates markets you can't serve directly.
Why a Niche Licensing Strategy Is a Top Opportunity
Niche IP in specialized industries often commands premium royalty rates precisely because the market is too small or regulated for large players to serve well.
How to Pivot Into an R&D Innovation Strategy
How companies use licensing revenue to fund the next round of R&D — creating a self-sustaining cycle of innovation, tax credits, and royalty income.
Built for R&D-Intensive Businesses
If your business spends on research, development, or innovation — in any form — there's a high probability you qualify for R&D tax credits and could benefit from an IP licensing strategy.
Medical Technology & Biotech
Device, diagnostic, therapeutic, and biologics companies with significant R&D spend — typically among the highest qualifying industries.
Pharmaceuticals & Life Sciences
Drug development, formulation, clinical research, and related activities qualify broadly — often generating credits to offset substantial licensing income.
High Technology & Software
Software development, algorithm design, platform engineering, and digital product R&D all commonly qualify — including activities businesses don't recognize as R&D.
Manufacturing & Engineering
Process development, tooling, testing, and manufacturing innovation qualify in ways most manufacturers miss — especially when R&D leads to licensable process IP.
Agriculture & AgTech
Crop science, precision agriculture, plant genetics, and AgTech platform development increasingly qualify — with significant licensing upside.
Clean Energy & Cleantech
Energy storage, solar, efficiency technology, and environmental innovation are among the fastest-growing R&D credit categories — with significant licensing potential.
Two Experts. One Integrated Strategy.
This workshop brings together an IP licensing strategist and a tax credit specialist — covering both sides of the R&D revenue equation in a single session.
Rand Brenner
Rand Brenner is President and CEO of Licensing Consulting Group, specializing in strategic IP consulting, licensing management, and IP due diligence. He has an extensive career as both licensee and licensor across multiple industries, including developing licensing programs for Mighty Morphin Power Rangers and Batman. Author of Hidden Wealth: The Money Making Power of Licensing (2019).
Greg Pfeuffer
Greg Pfeuffer is a Partner at Mueller Prost leading the Orange County office. Greg's focus is finding ways for CEOs, CFOs, and accounting teams to generate profit and cash flow — particularly through tax incentives and savings. He works with clients to identify and maximize R&D tax credit opportunities, turning innovation spending into direct bottom-line impact.
Let's Talk About Your R&D IP & Licensing Strategy
Schedule a private 15-minute strategy session with Rand Brenner to explore how licensing can help you capitalize on your R&D investments — and what a combined credit and licensing strategy might look like for your business.
15 minutes · Free · No obligation · Via video call